{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:44:10Z","timestamp":1790394250070,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,10,31]],"date-time":"2014-10-31T00:00:00Z","timestamp":1414713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1038\/cdd.2014.168","type":"journal-article","created":{"date-parts":[[2014,10,31]],"date-time":"2014-10-31T14:07:08Z","timestamp":1414764428000},"page":"767-778","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Loss of c-REL but not NF-\u03baB2 prevents autoimmune disease driven by FasL mutation"],"prefix":"10.1038","volume":"22","author":[{"given":"L A","family":"O'Reilly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Waring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Siebenlist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D H D","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Gerondakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Strasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,31]]},"reference":[{"key":"BFcdd2014168_CR1","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/0092-8674(91)90362-3","volume":"67","author":"A Strasser","year":"1991","unstructured":"Strasser A, Harris AW, Cory S . Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 1991; 67: 889\u2013899.","journal-title":"Cell"},{"key":"BFcdd2014168_CR2","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/nature03724","volume":"435","author":"CC Goodnow","year":"2005","unstructured":"Goodnow CC, Sprent J, Fazekas de St Groth B, Vinuesa CG . Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 2005; 435: 590\u2013597.","journal-title":"Nature"},{"key":"BFcdd2014168_CR3","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/415922a","volume":"415","author":"P Bouillet","year":"2002","unstructured":"Bouillet P, Purton JF, Godfrey DI, Zhang L-C, Coultas L, Puthalakath H et al. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 2002; 415: 922\u2013926.","journal-title":"Nature"},{"key":"BFcdd2014168_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.immuni.2009.01.001","volume":"30","author":"A Strasser","year":"2009","unstructured":"Strasser A, Jost PJ, Nagata S . The many roles of FAS receptor signaling in the immune system. Immunity 2009; 30: 180\u2013192.","journal-title":"Immunity"},{"key":"BFcdd2014168_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.immuni.2007.12.017","volume":"28","author":"PD Hughes","year":"2008","unstructured":"Hughes PD, Belz GT, Fortner K, Budd RC, Strasser A, Bouillet P . Apoptosis regulators Fas and Bim cooperate in shutdown of chronic immune responses and prevention of autoimmunity. Immunity 2008; 28: 197\u2013205.","journal-title":"Immunity"},{"key":"BFcdd2014168_CR6","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/356314a0","volume":"356","author":"R Watanabe-Fukunaga","year":"1992","unstructured":"Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S . Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314\u2013317.","journal-title":"Nature"},{"key":"BFcdd2014168_CR7","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/0092-8674(95)90013-6","volume":"81","author":"GH Fisher","year":"1995","unstructured":"Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middelton LA, Lin AY et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995; 81: 935\u2013946.","journal-title":"Cell"},{"key":"BFcdd2014168_CR8","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/nature08402","volume":"461","author":"LA O'Reilly","year":"2009","unstructured":"O'Reilly LA, Tai L, Lee L, Kruse EA, Grabow S, Fairlie WD et al. Membrane-bound Fas ligand only is essential for Fas-induced apoptosis. Nature 2009; 461: 659\u2013663.","journal-title":"Nature"},{"key":"BFcdd2014168_CR9","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/35037728","volume":"407","author":"PH Krammer","year":"2000","unstructured":"Krammer PH . CD95's deadly mission in the immune system. Nature 2000; 407: 789\u2013795.","journal-title":"Nature"},{"key":"BFcdd2014168_CR10","doi-asserted-by":"publisher","first-page":"47100","DOI":"10.1074\/jbc.M107385200","volume":"276","author":"JH Ahn","year":"2001","unstructured":"Ahn JH, Park SM, Cho HS, Lee MS, Yoon JB, Vilcek J et al. Non-apoptotic signaling pathways activated by soluble Fas ligand in serum-starved human fibroblasts. Mitogen-activated protein kinases and NF-kappaB-dependent gene expression. J Biol Chem 2001; 276: 47100\u201347106.","journal-title":"J Biol Chem"},{"key":"BFcdd2014168_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ni0302-221","volume":"3","author":"M Karin","year":"2002","unstructured":"Karin M, Lin A . NF-\u03baB at the crossroads of life and death. Nat Immunol 2002; 3: 221\u2013227.","journal-title":"Nat Immunol"},{"key":"BFcdd2014168_CR12","doi-asserted-by":"publisher","first-page":"6781","DOI":"10.1038\/sj.onc.1209944","volume":"25","author":"S Gerondakis","year":"2006","unstructured":"Gerondakis S, Grumont R, Gugasyan R, Wong L, Isomura I, Ho W et al. Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models. Oncogene 2006; 25: 6781\u20136799.","journal-title":"Oncogene"},{"key":"BFcdd2014168_CR13","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","volume":"132","author":"MS Hayden","year":"2008","unstructured":"Hayden MS, Ghosh S . Shared principles in NF-kappaB signaling. Cell 2008; 132: 344\u2013362.","journal-title":"Cell"},{"key":"BFcdd2014168_CR14","doi-asserted-by":"publisher","first-page":"6680","DOI":"10.1038\/sj.onc.1209954","volume":"25","author":"TD Gilmore","year":"2006","unstructured":"Gilmore TD . Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 2006; 25: 6680\u20136684.","journal-title":"Oncogene"},{"key":"BFcdd2014168_CR15","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1146\/annurev.immunol.021908.132641","volume":"27","author":"S Vallabhapurapu","year":"2009","unstructured":"Vallabhapurapu S, Karin M . Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 2009; 27: 693\u2013733.","journal-title":"Annu Rev Immunol"},{"key":"BFcdd2014168_CR16","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/ar2457","volume":"10","author":"KD Brown","year":"2008","unstructured":"Brown KD, Claudio E, Siebenlist U . The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis. Arthritis Res Ther 2008; 10: 212.","journal-title":"Arthritis Res Ther"},{"key":"BFcdd2014168_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jaut.2008.04.012","volume":"31","author":"S Pai","year":"2008","unstructured":"Pai S, Thomas R . Immune deficiency or hyperactivity-Nf-kappab illuminates autoimmunity. J Autoimmun 2008; 31: 245\u2013251.","journal-title":"J Autoimmun"},{"key":"BFcdd2014168_CR18","doi-asserted-by":"publisher","first-page":"38617","DOI":"10.1074\/jbc.M606705200","volume":"281","author":"B Zhang","year":"2006","unstructured":"Zhang B, Wang Z, Ding J, Peterson P, Gunning WT, Ding HF . NF-kappaB2 is required for the control of autoimmunity by regulating the development of medullary thymic epithelial cells. J Biol Chem 2006; 281: 38617\u201338624.","journal-title":"J Biol Chem"},{"key":"BFcdd2014168_CR19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nri1629","volume":"5","author":"U Siebenlist","year":"2005","unstructured":"Siebenlist U, Brown K, Claudio E . Control of lymphocyte development by nuclear factor-kappaB. Nat Rev Immunol 2005; 5: 435\u2013445.","journal-title":"Nat Rev Immunol"},{"key":"BFcdd2014168_CR20","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1210\/me.2011-0068","volume":"25","author":"JR Flammer","year":"2011","unstructured":"Flammer JR, Rogatsky I . Minireview: Glucocorticoids in autoimmunity: unexpected targets and mechanisms. Mol Endocrinol 2011; 25: 1075\u20131086.","journal-title":"Mol Endocrinol"},{"key":"BFcdd2014168_CR21","first-page":"245","volume":"5","author":"RJ Grumont","year":"1990","unstructured":"Grumont RJ, Gerondakis S . The murine c-rel proto-oncogene encodes two mRNAs the expression of which is modulated by lymphoid stimuli. Oncogene Res 1990; 5: 245\u2013254.","journal-title":"Oncogene Res"},{"key":"BFcdd2014168_CR22","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1073\/pnas.93.8.3405","volume":"93","author":"S Gerondakis","year":"1996","unstructured":"Gerondakis S, Strasser A, Metcalf D, Grigoriadis G, Scheerlinck J-PY, Grumont RJ . Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor. Proc Natl Acad Sci USA 1996; 93: 3405\u20133409.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcdd2014168_CR23","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1177\/1947601911421925","volume":"2","author":"TD Gilmore","year":"2011","unstructured":"Gilmore TD, Gerondakis S . The c-Rel transcription factor in development and disease. Genes Cancer 2011; 2: 695\u2013711.","journal-title":"Genes Cancer"},{"key":"BFcdd2014168_CR24","first-page":"85","volume":"87","author":"JH Caama\u00f1o","year":"19998","unstructured":"Caama\u00f1o JH, Rizzo CA, Durham SK, Barton DS, Ravent\u00f3s-Su\u00e1rez C, Snapper CM et al. Nuclear factor (NF)-\u03baB2 (p100\/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J Exp Med 998; 87: 85\u201396.","journal-title":"J Exp Med"},{"key":"BFcdd2014168_CR25","first-page":"47","volume":"87","author":"G Franzoso","year":"19998","unstructured":"Franzoso G, Carlson L, Poljak L, Shores EW, Epstein S, Leonardi A et al. Mice deficient in nuclear factor (NF)-\u03baB\/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J Exp Med 998; 87: 47\u201359.","journal-title":"J Exp Med"},{"key":"BFcdd2014168_CR26","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1172\/JCI28326","volume":"116","author":"M Zhu","year":"2006","unstructured":"Zhu M, Chin RK, Christiansen PA, Lo JC, Liu X, Ware C et al. NF-kappaB2 is required for the establishment of central tolerance through an Aire-dependent pathway. J Clin Invest 2006; 116: 2964\u20132971.","journal-title":"J Clin Invest"},{"key":"BFcdd2014168_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0896-8411(02)00109-9","volume":"20","author":"D Braun","year":"2003","unstructured":"Braun D, Geraldes P, Demengeot J . Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice. J Autoimmun 2003; 20: 15\u201325.","journal-title":"J Autoimmun"},{"key":"BFcdd2014168_CR28","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1101\/gad.9.16.1965","volume":"9","author":"F K\u00f6ntgen","year":"1995","unstructured":"K\u00f6ntgen F, Grumont RJ, Strasser A, Metcalf D, Li R, Tarlinton D et al. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev 1995; 9: 1965\u20131977.","journal-title":"Genes Dev"},{"key":"BFcdd2014168_CR29","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1038\/jid.2009.71","volume":"129","author":"T Werfel","year":"2009","unstructured":"Werfel T . The role of leukocytes, keratinocytes, and allergen-specific IgE in the development of atopic dermatitis. J Invest Dermatol 2009; 129: 1878\u20131891.","journal-title":"J Invest Dermatol"},{"key":"BFcdd2014168_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/ni.1818","volume":"11","author":"K Wing","year":"2010","unstructured":"Wing K, Sakaguchi S . Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 2010; 11: 7\u201313.","journal-title":"Nat Immunol"},{"key":"BFcdd2014168_CR31","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.jaci.2005.09.004","volume":"116","author":"M Akdis","year":"2005","unstructured":"Akdis M, Blaser K, Akdis CA . T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. J Allergy Clin Immunol 2005; 116: 961\u2013968 quiz 969.","journal-title":"J Allergy Clin Immunol"},{"key":"BFcdd2014168_CR32","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1038\/jid.2012.40","volume":"132","author":"N Fyhrquist","year":"2012","unstructured":"Fyhrquist N, Lehtimaki S, Lahl K, Savinko T, Lappetelainen AM, Sparwasser T et al. Foxp3+ cells control Th2 responses in a murine model of atopic dermatitis. J Invest Dermatol 2012; 132: 1672\u20131680.","journal-title":"J Invest Dermatol"},{"key":"BFcdd2014168_CR33","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1084\/jem.20091411","volume":"206","author":"I Isomura","year":"2009","unstructured":"Isomura I, Palmer S, Grumont RJ, Bunting K, Hoyne G, Wilkinson N et al. c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells. J Exp Med 2009; 206: 3001\u20133014.","journal-title":"J Exp Med"},{"key":"BFcdd2014168_CR34","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/annurev.immunol.25.022106.141532","volume":"27","author":"D Mathis","year":"2009","unstructured":"Mathis D, Benoist C . Aire. Annu Rev Immunol 2009; 27: 287\u2013312.","journal-title":"Annu Rev Immunol"},{"key":"BFcdd2014168_CR35","doi-asserted-by":"publisher","first-page":"18193","DOI":"10.1073\/pnas.0709160104","volume":"104","author":"DH Gray","year":"2007","unstructured":"Gray DH, Gavanescu I, Benoist C, Mathis D . Danger-free autoimmune disease in Aire-deficient mice. Proc Natl Acad Sci USA 2007; 104: 18193\u201318198.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcdd2014168_CR36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.it.2009.11.002","volume":"31","author":"M Irla","year":"2010","unstructured":"Irla M, Hollander G, Reith W . Control of central self-tolerance induction by autoreactive CD4(+) thymocytes. Trends Immunol 2010; 31: 71\u201379.","journal-title":"Trends Immunol"},{"key":"BFcdd2014168_CR37","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.tips.2007.01.005","volume":"28","author":"J Strnad","year":"2007","unstructured":"Strnad J, Burke JR . IkappaB kinase inhibitors for treating autoimmune and inflammatory disorders: potential and challenges. Trends Pharmacol Sci 2007; 28: 142\u2013148.","journal-title":"Trends Pharmacol Sci"},{"key":"BFcdd2014168_CR38","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1002\/1521-4141(200109)31:9<2612::AID-IMMU2612>3.0.CO;2-C","volume":"31","author":"S Vallabhapurapu","year":"2001","unstructured":"Vallabhapurapu S, Ryseck RP, Malewicz M, Weih DS, Weih F . Inhibition of NF-\u03baB in T cells blocks lymphoproliferation and partially rescues autoimmune disease in gld\/gld mice. Eur J Immunol 2001; 31: 2612\u20132622.","journal-title":"Eur J Immunol"},{"key":"BFcdd2014168_CR39","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.immuni.2008.07.016","volume":"29","author":"Z Hao","year":"2008","unstructured":"Hao Z, Duncan GS, Seagal J, Su YW, Hong C, Haight J et al. Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis. Immunity 2008; 29: 615\u2013627.","journal-title":"Immunity"},{"key":"BFcdd2014168_CR40","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.cell.2006.12.033","volume":"128","author":"S Basak","year":"2007","unstructured":"Basak S, Kim H, Kearns JD, Tergaonkar V, O'Dea E, Werner SL et al. A fourth IkappaB protein within the NF-kappaB signaling module. Cell 2007; 128: 369\u2013381.","journal-title":"Cell"},{"key":"BFcdd2014168_CR41","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/ni1351","volume":"7","author":"N Ishimaru","year":"2006","unstructured":"Ishimaru N, Kishimoto H, Hayashi Y, Sprent J . Regulation of naive T cell function by the NF-kappaB2 pathway. Nat Immunol 2006; 7: 763\u2013772.","journal-title":"Nat Immunol"},{"key":"BFcdd2014168_CR42","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1042\/bj3500735","volume":"350","author":"K Brady","year":"2000","unstructured":"Brady K, Fitzgerald S, Moynagh PN . Tumour-necrosis-factor-receptor-associated factor 6, NF-kappaB-inducing kinase and IkappaB kinases mediate IgE isotype switching in response to CD40. Biochem J 2000; 350: 735\u2013740.","journal-title":"Biochem J"},{"key":"BFcdd2014168_CR43","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1038\/sj.gt.3301724","volume":"9","author":"H Nakamura","year":"2002","unstructured":"Nakamura H, Aoki M, Tamai K, Oishi M, Ogihara T, Kaneda Y et al. Prevention and regression of atopic dermatitis by ointment containing NF-kB decoy oligodeoxynucleotides in NC\/Nga atopic mouse model. Gene Ther 2002; 9: 1221\u20131229.","journal-title":"Gene Ther"},{"key":"BFcdd2014168_CR44","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1093\/intimm\/12.8.1167","volume":"12","author":"P Zelazowski","year":"2000","unstructured":"Zelazowski P, Shen Y, Snapper CM . NF-kappaB\/p50 and NF-kappaB\/c-Rel differentially regulate the activity of the 3'alphaE-hsl,2 enhancer in normal murine B cells in an activation-dependent manner. Int Immunol 2000; 12: 1167\u20131172.","journal-title":"Int Immunol"},{"key":"BFcdd2014168_CR45","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1084\/jem.187.7.973","volume":"187","author":"D Carrasco","year":"1998","unstructured":"Carrasco D, Cheng J, Lewin A, Warr G, Yang H, Rizzo C et al. Multiple hemopoietic defects and lymphoid hyperplasia in mice lacking the transcriptional activation domain of the c-Rel protein. J Exp Med 1998; 187: 973\u2013984.","journal-title":"J Exp Med"},{"key":"BFcdd2014168_CR46","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1172\/JCI8298","volume":"105","author":"IK Campbell","year":"2000","unstructured":"Campbell IK, Gerondakis S, O'Donnell K, Wicks IP . Distinct roles for the NF-kappaB1 (p50) and c-Rel transcription factors in inflammatory arthritis. J Clin Invest 2000; 105: 1799\u20131806.","journal-title":"J Clin Invest"},{"key":"BFcdd2014168_CR47","doi-asserted-by":"publisher","first-page":"4886","DOI":"10.4049\/jimmunol.171.9.4886","volume":"171","author":"SE Lamhamedi-Cherradi","year":"2003","unstructured":"Lamhamedi-Cherradi SE, Zheng S, Hilliard BA, Xu L, Sun J, Alsheadat S et al. Transcriptional regulation of type I diabetes by NF-kappa B. J Immunol 2003; 171: 4886\u20134892.","journal-title":"J Immunol"},{"key":"BFcdd2014168_CR48","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.4049\/jimmunol.1101757","volume":"187","author":"G Chen","year":"2011","unstructured":"Chen G, Hardy K, Pagler E, Ma L, Lee S, Gerondakis S et al. The NF-kappaB transcription factor c-Rel is required for Th17 effector cell development in experimental autoimmune encephalomyelitis. J Immunol 2011; 187: 4483\u20134491.","journal-title":"J Immunol"},{"key":"BFcdd2014168_CR49","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1172\/JCI0215254","volume":"110","author":"BA Hilliard","year":"2002","unstructured":"Hilliard BA, Mason N, Xu L, Sun J, Lamhamedi-Cherradi SE, Liou HC et al. Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation. J Clin Invest 2002; 110: 843\u2013850.","journal-title":"J Clin Invest"},{"key":"BFcdd2014168_CR50","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/ni.2090","volume":"12","author":"M Chang","year":"2011","unstructured":"Chang M, Jin W, Chang JH, Xiao Y, Brittain GC, Yu J et al. The ubiquitin ligase Peli1 negatively regulates T cell activation and prevents autoimmunity. Nat Immunol 2011; 12: 1002\u20131009.","journal-title":"Nat Immunol"},{"key":"BFcdd2014168_CR51","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cell.2007.06.033","volume":"130","author":"CC Goodnow","year":"2007","unstructured":"Goodnow CC . Multistep pathogenesis of autoimmune disease. Cell 2007; 130: 25\u201335.","journal-title":"Cell"},{"key":"BFcdd2014168_CR52","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0022-1759(01)00493-8","volume":"260","author":"DH Gray","year":"2002","unstructured":"Gray DH, Chidgey AP, Boyd RL . Analysis of thymic stromal cell populations using flow cytometry. J Immunol Methods 2002; 260: 15\u201328.","journal-title":"J Immunol Methods"},{"key":"BFcdd2014168_CR53","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jim.2007.09.010","volume":"329","author":"DH Gray","year":"2008","unstructured":"Gray DH, Fletcher AL, Hammett M, Seach N, Ueno T, Young LF et al. Unbiased analysis, enrichment and purification of thymic stromal cells. J Immunol Methods 2008; 329: 56\u201366.","journal-title":"J Immunol Methods"},{"key":"BFcdd2014168_CR54","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jim.2012.07.023","volume":"385","author":"N Seach","year":"2012","unstructured":"Seach N, Wong K, Hammett M, Boyd RL, Chidgey AP . Purified enzymes improve isolation and characterization of the adult thymic epithelium. J Immunol Methods 2012; 385: 23\u201334.","journal-title":"J Immunol Methods"},{"key":"BFcdd2014168_CR55","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1182\/blood-2002-10-3186","volume":"102","author":"S Naik","year":"2003","unstructured":"Naik S, Vremec D, Wu L, O'Keeffe M, Shortman K . CD8alpha+ mouse spleen dendritic cells do not originate from the CD8alpha- dendritic cell subset. Blood 2003; 102: 601\u2013604.","journal-title":"Blood"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cdd2014168.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cdd2014168","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cdd2014168.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:06:25Z","timestamp":1684415185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cdd2014168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,31]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["BFcdd2014168"],"URL":"https:\/\/doi.org\/10.1038\/cdd.2014.168","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,31]]},"assertion":[{"value":"4 May 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}